BackGeovax Labs- Warrants (01/01/2025) Overview

Geovax Labs- Warrants (01/01/2025) Current Cash

Track Geovax Labs- Warrants (01/01/2025)'s current cash ($3.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$3.14M
1.60% YoYΔ $49560.00 vs prior year quarter

Peer average

Loading

Geovax Labs- Warrants (01/01/2025) Current Cash History

Loading

Geovax Labs- Warrants (01/01/2025) vs. peers: Current Cash Comparison

Loading

Geovax Labs- Warrants (01/01/2025) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Geovax Labs- Warrants (01/01/2025) (GOVXW) FAQ

The latest current cash for GOVXW is $3.1M as of June 2026. That compares with $3.1M in the prior-year period — up 1.6% year over year. Investors often review this figure alongside Geovax Labs- Warrants (01/01/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, GOVXW's current cash moved from $3.1M to $3.1M — a 1.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Geovax Labs- Warrants (01/01/2025)'s operating scale or balance-sheet position.

A current cash figure of $3.1M for GOVXW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GOVXW's current cash ($3.1M), review year-over-year change from $3.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Geovax Labs- Warrants (01/01/2025)'s current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.